Research & Development
We are embracing the best production methodologies and partnerships that leverage the power of our creative structure to advance science and develop safe and innovative new products to our patient and adult-use cannabis consumer base.
InPlanta Biotechnology, a leading cannabis R&D company based in Lethbridge, Alberta, has partnered with Canada House Wellness Group and Abba Medix Corp. on the production of a Veteran focused line of cannabis products to be offered exclusively to registered Abba patients.
Dr. Darryl Hudson from InPlanta, began assessing cannabis varieties for their efficacy on Veterans battling PTSD. Through this research, it was observed that high THC Kush varieties with specific terpene profiles were effective for reducing the symptoms of both PTSD and pain, as well as alleviating the “hypervigilance syndrome” that is prevalent in many who have fought in recent wars. InPlanta, in collaboration with top breeders in British Columbia, enhanced these properties through traditional breeding efforts.
Canada House Wellness Group and IsoCanMed Inc. has partnered with Université Laval top searchers to create high quality, tailor-made nutrients for IsoCanMed’s facility who is employing unique state-of-the-art vertical, aeroponic production methodologies allowing them to grow best-in-class indoor cannabis.
In parallel, innovative cannabis 2.O products are being developped in collaboration with Université Laval that should be released in the near future. Stay tuned!
Canada House Wellness Group and Abba Medix Corp. has partnered with Organic Extraction Technologies (“OET”} is currently employing equipment and services sourced from OET to produce solventless cannabis rosin at its Pickering, Ontario facility.
Solventless extraction without chemicals or additives only works with high quality cannabis. Abba solventless products will allow them to showcase some of the best flower and trim in the industry.
